These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 30516758)

  • 1. Prevention of sudden cardiac death by the implantable cardioverter-defibrillator.
    Hindricks G; Lenarczyk R; Kalarus Z; Döring M; Shamloo AS; Dagres N
    Pol Arch Intern Med; 2018 Dec; 128(12):764-770. PubMed ID: 30516758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient barriers to implantable cardioverter defibrillator implantation for the primary prevention of sudden cardiac death in patients with heart failure and reduced ejection fraction.
    Chan LL; Lim CP; Aung ST; Quetua P; Ho KL; Chong D; Teo WS; Sim D; Ching CK
    Singapore Med J; 2016 Apr; 57(4):182-7. PubMed ID: 27075476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determinants of patient survival rate after implantation of a cardioverter-defibrillator without resynchronisation capability.
    Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B
    Kardiol Pol; 2012; 70(11):1099-110. PubMed ID: 23180517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance of the entirely subcutaneous ICD in borderline indications.
    Willy K; Reinke F; Bögeholz N; Köbe J; Eckardt L; Frommeyer G
    Clin Res Cardiol; 2020 Jun; 109(6):694-699. PubMed ID: 31586219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sudden cardiac death unresponsive to implantable defibrillator therapy: an urgent target for clinicians, industry and government.
    Anderson KP
    J Interv Card Electrophysiol; 2005 Nov; 14(2):71-8. PubMed ID: 16374553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utilization rates of implantable cardioverter-defibrillators for primary prevention of sudden cardiac death: a 2012 calculation for a midwestern health referral region.
    Hoang A; Shen C; Zheng J; Taylor S; Groh WJ; Rosenman M; Buxton AE; Chen PS
    Heart Rhythm; 2014 May; 11(5):849-55. PubMed ID: 24566233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implantable Cardioverter-Defibrillator Placement for Primary Prevention in 2,346 Patients: Predictors of One-Year Survival.
    Merchant FM; Desai Y; Addish MA; Kelly K; Casey M; Goyal A; Leon AR; El-Chami MF
    Tex Heart Inst J; 2018 Aug; 45(4):221-225. PubMed ID: 30374229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implantable cardioverter-defibrillators in heart failure patients with reduced ejection fraction and diabetes.
    Sharma A; Al-Khatib SM; Ezekowitz JA; Cooper LB; Fordyce CB; Michael Felker G; Bardy GH; Poole JE; Thomas Bigger J; Buxton AE; Moss AJ; Friedman DJ; Lee KL; Steinman R; Dorian P; Cappato R; Kadish AH; Kudenchuk PJ; Mark DB; Peterson ED; Inoue LYT; Sanders GD
    Eur J Heart Fail; 2018 Jun; 20(6):1031-1038. PubMed ID: 29761861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic Review for the 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.
    Kusumoto FM; Bailey KR; Chaouki AS; Deshmukh AJ; Gautam S; Kim RJ; Kramer DB; Lambrakos LK; Nasser NH; Sorajja D
    J Am Coll Cardiol; 2018 Oct; 72(14):1653-1676. PubMed ID: 29097297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary prevention of sudden cardiac death using implantable cardioverter defibrillators.
    Ding L; Hua W; Niu H; Chen K; Zhang S
    Europace; 2008 Sep; 10(9):1034-41. PubMed ID: 18559335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-Term Experience With the Subcutaneous Implantable Cardioverter-Defibrillator in Teenagers and Young Adults.
    Bettin M; Larbig R; Rath B; Fischer A; Frommeyer G; Reinke F; Köbe J; Eckardt L
    JACC Clin Electrophysiol; 2017 Dec; 3(13):1499-1506. PubMed ID: 29759830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usefulness of sleep-disordered breathing to predict occurrence of appropriate and inappropriate implantable-cardioverter defibrillator therapy in patients with implantable cardioverter-defibrillator for primary prevention of sudden cardiac death.
    Kreuz J; Skowasch D; Horlbeck F; Atzinger C; Schrickel JW; Lorenzen H; Nickenig G; Schwab JO
    Am J Cardiol; 2013 May; 111(9):1319-23. PubMed ID: 23411108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current challenges in sudden cardiac death prevention.
    Corrado D; Zorzi A; Vanoli E; Gronda E
    Heart Fail Rev; 2020 Jan; 25(1):99-106. PubMed ID: 31346843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term Outcomes Associated With Implantable Cardioverter Defibrillator in Adults With Chronic Kidney Disease.
    Bansal N; Szpiro A; Reynolds K; Smith DH; Magid DJ; Gurwitz JH; Masoudi F; Greenlee RT; Tabada GH; Sung SH; Dighe A; Go AS
    JAMA Intern Med; 2018 Mar; 178(3):390-398. PubMed ID: 29404570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decision-making regarding subcutaneous implantable cardioverter defibrillator as primary prevention in patients with low ejection fraction.
    Ngan HT; Li KY; Wong SL; Tse HF
    Pacing Clin Electrophysiol; 2024 Oct; 47(10):1285-1292. PubMed ID: 39161154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Non-pharmacologic prevention of sudden cardiac death].
    Jurkovicová O; Cagán S
    Bratisl Lek Listy; 1997; 98(7-8):423-39. PubMed ID: 9471337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk stratification for implantable cardioverter defibrillator therapy: the role of the wearable cardioverter-defibrillator.
    Klein HU; Goldenberg I; Moss AJ
    Eur Heart J; 2013 Aug; 34(29):2230-42. PubMed ID: 23729691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical management and prevention of sudden cardiac death.
    Yousuf O; Chrispin J; Tomaselli GF; Berger RD
    Circ Res; 2015 Jun; 116(12):2020-40. PubMed ID: 26044254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Negative result of microvolt T-wave alternans test is helpful in scheduling the order of cardioverter-defibrillator implantation in primary prevention of sudden cardiac death in individuals with the left ventricular systolic dysfunction].
    Daniłowicz-Szymanowicz L; Szwoch M; Raczak J; Raczak G
    Pol Merkur Lekarski; 2012 Oct; 33(196):193-7. PubMed ID: 23272605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of microvolt T-wave alternans testing in scheduling implantable cardioverter-defibrillator placement for the primary prevention of sudden cardiac death in patients with left ventricular dysfunction.
    Daniłowicz-Szymanowicz L; Suchecka J; Zagożdżon P; Szwoch M; Kempa M; Raczak G
    Kardiol Pol; 2015; 73(6):429-36. PubMed ID: 25371309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.